NPM3 as a novel oncogenic factor and poor prognostic marker contributes to cell proliferation and migration in lung adenocarcinoma

BACKGROUND: Lung cancer is the leading cause of cancer-related deaths worldwide, and despite recent advances in targeted therapies and immunotherapies, the clinical benefit remains limited. Therefore, there is an urgent need to further investigate the molecular mechanisms underlying lung cancer. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Shan, Xing, Jing, Lu, Kaining, Wang, Kai, Yu, Wanjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230701/
https://www.ncbi.nlm.nih.gov/pubmed/37254219
http://dx.doi.org/10.1186/s41065-023-00289-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230701/
https://www.ncbi.nlm.nih.gov/pubmed/37254219
http://dx.doi.org/10.1186/s41065-023-00289-6

Ejemplares similares